{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:36:59Z","timestamp":1787668619275,"version":"build-2736575974"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:00:00Z","timestamp":1579737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:00:00Z","timestamp":1579737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Invasive candidiasis (IC) is the most common nosocomial infection and a leading cause of mycoses-related deaths. High-systemic toxicity and emergence of antifungal-resistant species warrant the development of newer preventive approaches against IC. Here, we have adopted an immunotherapeutic peptide vaccine-based approach, to enhance the body\u2019s immune response against invasive candida infections. Using computational tools, we screened the entire candida proteome (6030 proteins) and identified the most immunodominant HLA class I, HLA class II and B- cell epitopes. By further immunoinformatic analyses for enhanced vaccine efficacy, we selected the 18- most promising epitopes, which were joined together using molecular linkers to create a <jats:underline>m<\/jats:underline>ulti<jats:underline>v<\/jats:underline>alent recombinant <jats:underline>p<\/jats:underline>rotein against <jats:italic><jats:underline>C<\/jats:underline><\/jats:italic><jats:italic>andida albicans<\/jats:italic> (mvPC). To increase mvPC\u2019s immunogenicity, we added a synthetic adjuvant (RS09) to the mvPC design. The selected mvPC epitopes are homologous against all currently available annotated reference sequences of 22\u2009<jats:italic>C. albicans<\/jats:italic> strains, thus offering a higher coverage and greater protective response. A major advantage of the current vaccine approach is mvPC\u2019s multivalent nature (recognizing multiple-epitopes), which is likely to provide enhanced protection against complex candida antigens. Here, we describe the computational analyses leading to mvPC design.<\/jats:p>","DOI":"10.1038\/s41598-020-57906-x","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T11:02:58Z","timestamp":1579777378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["In silico Design of a Multivalent Vaccine Against Candida albicans"],"prefix":"10.1038","volume":"10","author":[{"given":"Shikha","family":"Tarang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Kesherwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake","family":"LaTendresse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laramie","family":"Lindgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia M.","family":"Rocha-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Weston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,23]]},"reference":[{"key":"57906_CR1","doi-asserted-by":"publisher","first-page":"18026","DOI":"10.1038\/nrdp.2018.26","volume":"4","author":"PG Pappas","year":"2018","unstructured":"Pappas, P. G., Lionakis, M. S., Arendrup, M. C., Ostrosky-Zeichner, L. & Kullberg, B. J. Invasive candidiasis. Nat Rev Dis Primers. 4, 18026, https:\/\/doi.org\/10.1038\/nrdp.2018.26 (2018).","journal-title":"Nat Rev Dis Primers."},{"key":"57906_CR2","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1517\/17460441.2013.807245","volume":"8","author":"CG Pierce","year":"2013","unstructured":"Pierce, C. G. & Lopez-Ribot, J. L. Candidiasis drug discovery and development: New approaches targeting virulence for discovering and identifying new drugs. Expert Opin Drug Discov. 8, 1117\u20131126 (2013).","journal-title":"Expert Opin Drug Discov."},{"key":"57906_CR3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0891-5520(02)00042-9","volume":"16","author":"JA Vazquez","year":"2002","unstructured":"Vazquez, J. A. & Sobel, J. D. Mucosal candidiasis. Infect Dis Clin North Am. 16, 793\u2013820 (2002).","journal-title":"Infect Dis Clin North Am."},{"key":"57906_CR4","unstructured":"Mora Carpio, A. L. & Climaco, A. Candidiasis, fungemia. (StatPearls Publishing LLC, 2019)."},{"key":"57906_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4161\/viru.22913","volume":"4","author":"FL Mayer","year":"2013","unstructured":"Mayer, F. L., Wilson, D. & Hube, B. Candida albicans pathogenicity mechanisms. Virulence. 4, 119\u2013128 (2013).","journal-title":"Virulence."},{"key":"57906_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/TCRM.S40160","volume":"10","author":"N Yapar","year":"2014","unstructured":"Yapar, N. Epidemiology and risk factors for invasive candidiasis. Ther Clin Risk Manag. 10, 95\u2013105 (2014).","journal-title":"Ther Clin Risk Manag."},{"key":"57906_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2147\/IDR.S80677","volume":"8","author":"R Hirano","year":"2015","unstructured":"Hirano, R., Sakamoto, Y., Kudo, K. & Ohnishi, M. Retrospective analysis of mortality and candida isolates of 75 patients with candidemia: A single hospital experience. Infect Drug Resist. 8, 199\u2013205 (2015).","journal-title":"Infect Drug Resist."},{"key":"57906_CR8","doi-asserted-by":"publisher","first-page":"4419","DOI":"10.1128\/JCM.42.10.4419-4431.2004","volume":"42","author":"MA Pfaller","year":"2004","unstructured":"Pfaller, M. A. & Diekema, D. J. Rare and emerging opportunistic fungal pathogens: Concern for resistance beyond candida albicans and aspergillus fumigatus. J Clin Microbiol. 42, 4419\u20134431 (2004).","journal-title":"J Clin Microbiol."},{"key":"57906_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.mib.2016.08.006","volume":"34","author":"A da Silva Dantas","year":"2016","unstructured":"da Silva Dantas, A. et al. Cell biology of candida albicans-host interactions. Curr Opin Microbiol. 34, 111\u2013118 (2016).","journal-title":"Curr Opin Microbiol."},{"key":"57906_CR10","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.1016\/j.vaccine.2012.04.069","volume":"30","author":"F De Bernardis","year":"2012","unstructured":"De Bernardis, F. et al. A virosomal vaccine against candidal vaginitis: Immunogenicity, efficacy and safety profile in animal models. Vaccine. 30, 4490\u20134498 (2012).","journal-title":"Vaccine."},{"key":"57906_CR11","doi-asserted-by":"publisher","first-page":"7594","DOI":"10.1016\/j.vaccine.2012.10.038","volume":"30","author":"CS Schmidt","year":"2012","unstructured":"Schmidt, C. S. et al. NDV-3, a recombinant alum-adjuvanted vaccine for candida and staphylococcus aureus, is safe and immunogenic in healthy adults. Vaccine. 30, 7594\u20137600 (2012).","journal-title":"Vaccine."},{"key":"57906_CR12","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.1016\/j.vaccine.2013.09.016","volume":"31","author":"AS Ibrahim","year":"2013","unstructured":"Ibrahim, A. S. et al. NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response. Vaccine. 31, 5549\u20135556 (2013).","journal-title":"Vaccine."},{"key":"57906_CR13","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1086\/503428","volume":"42","author":"J Pachl","year":"2006","unstructured":"Pachl, J. et al. A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis. Clin Infect Dis. 42, 1404\u20131413 (2006).","journal-title":"Clin Infect Dis."},{"key":"57906_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s12272-011-0307-9","volume":"34","author":"JH Lee","year":"2011","unstructured":"Lee, J. H., Jang, E. C. & Han, Y. Combination immunotherapy of MAb B6.1 with fluconazole augments therapeutic effect to disseminated candidiasis. Arch Pharm Res. 34, 399\u2013405 (2011).","journal-title":"Arch Pharm Res."},{"key":"57906_CR15","doi-asserted-by":"publisher","first-page":"e1003741","DOI":"10.1371\/journal.ppat.1003741","volume":"9","author":"C Jimenez-Lopez","year":"2013","unstructured":"Jimenez-Lopez, C. & Lorenz, M. C. Fungal immune evasion in a model host-pathogen interaction: Candida albicans versus macrophages. PLoS Pathog. 9, e1003741, https:\/\/doi.org\/10.1371\/journal.ppat.1003741 (2013).","journal-title":"PLoS Pathog."},{"key":"57906_CR16","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/nrmicro3156","volume":"11","author":"A Cassone","year":"2013","unstructured":"Cassone, A. Development of vaccines for candida albicans: Fighting a skilled transformer. Nat Rev Microbiol. 11, 884\u2013891 (2013).","journal-title":"Nat Rev Microbiol."},{"key":"57906_CR17","doi-asserted-by":"publisher","first-page":"e10155","DOI":"10.1371\/journal.pone.0010155","volume":"5","author":"P Sampaio","year":"2010","unstructured":"Sampaio, P. et al. Virulence attenuation of candida albicans genetic variants isolated from a patient with a recurrent bloodstream infection. PLoS One. 5, e10155, https:\/\/doi.org\/10.1371\/journal.pone.0010155 (2010).","journal-title":"PLoS One."},{"key":"57906_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova, I. A. & Flower, D. R. VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics. 8, 4, https:\/\/doi.org\/10.1186\/1471-2105-8-4 (2007).","journal-title":"BMC Bioinformatics."},{"key":"57906_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19456-1","volume":"8","author":"RK Pandey","year":"2018","unstructured":"Pandey, R. K., Bhatt, T. K. & Prajapati, V. K. Novel immunoinformatics approaches to design multi-epitope subunit vaccine for malaria by investigating anopheles salivary protein. Sci Rep. 8, 1125, https:\/\/doi.org\/10.1038\/s41598-018-19456-1 (2018).","journal-title":"Sci Rep."},{"key":"57906_CR20","doi-asserted-by":"publisher","first-page":"e99368","DOI":"10.1371\/journal.pone.0099368","volume":"9","author":"CS Yu","year":"2014","unstructured":"Yu, C. S. et al. CELLO2GO: A web server for protein subCELlular LOcalization prediction with functional gene ontology annotation. PLoS One. 9, e99368, https:\/\/doi.org\/10.1371\/journal.pone.0099368 (2014).","journal-title":"PLoS One."},{"key":"57906_CR21","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1128\/MMBR.62.1.130-180.1998","volume":"62","author":"WL Chaffin","year":"1998","unstructured":"Chaffin, W. L., Lopez-Ribot, J. L., Casanova, M., Gozalbo, D. & Martinez, J. P. Cell wall and secreted proteins of candida albicans: Identification, function, and expression. Microbiol Mol Biol Rev. 62, 130\u2013180 (1998).","journal-title":"Microbiol Mol Biol Rev."},{"key":"57906_CR22","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1002\/eji.200425811","volume":"35","author":"MV Larsen","year":"2005","unstructured":"Larsen, M. V. et al. An integrative approach to CTL epitope prediction: A combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions. Eur J Immunol. 35, 2295\u20132303 (2005).","journal-title":"Eur J Immunol."},{"key":"57906_CR23","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1093\/bioinformatics\/btx820","volume":"34","author":"M Andreatta","year":"2018","unstructured":"Andreatta, M. et al. An automated benchmarking platform for MHC class II binding prediction methods. Bioinformatics. 34, 1522\u20131528 (2018).","journal-title":"Bioinformatics."},{"key":"57906_CR24","doi-asserted-by":"publisher","first-page":"6760830","DOI":"10.1155\/2016\/6760830","volume":"2016","author":"L Potocnakova","year":"2016","unstructured":"Potocnakova, L., Bhide, M. & Pulzova, L. B. An introduction to B-cell epitope mapping and in silico epitope prediction. J Immunol Res. 2016, 6760830, https:\/\/doi.org\/10.1155\/2016\/6760830 (2016).","journal-title":"J Immunol Res."},{"key":"57906_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1142\/9781848162648_0011","volume":"7","author":"Y El-Manzalawy","year":"2008","unstructured":"El-Manzalawy, Y., Dobbs, D. & Honavar, V. Predicting flexible length linear B-cell epitopes. Comput Syst Bioinformatics Conf. 7, 121\u2013132 (2008).","journal-title":"Comput Syst Bioinformatics Conf."},{"key":"57906_CR26","doi-asserted-by":"publisher","first-page":"e30839","DOI":"10.1371\/journal.pone.0030839","volume":"7","author":"A Shanmugam","year":"2012","unstructured":"Shanmugam, A. et al. Synthetic toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants. PLoS One. 7, e30839, https:\/\/doi.org\/10.1371\/journal.pone.0030839 (2012).","journal-title":"PLoS One."},{"key":"57906_CR27","doi-asserted-by":"publisher","first-page":"e13677","DOI":"10.1371\/journal.pone.0013677","volume":"5","author":"RN Coler","year":"2010","unstructured":"Coler, R. N. et al. A synthetic adjuvant to enhance and expand immune responses to influenza vaccines. PLoS One. 5, e13677, https:\/\/doi.org\/10.1371\/journal.pone.0013677 (2010).","journal-title":"PLoS One."},{"key":"57906_CR28","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/nprot.2012.085","volume":"7","author":"M Kallberg","year":"2012","unstructured":"Kallberg, M. et al. Template-based protein structure modeling using the RaptorX web server. Nat Protoc. 7, 1511\u20131522 (2012).","journal-title":"Nat Protoc."},{"key":"57906_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-4939-0366-5_2","volume":"1137","author":"M Kallberg","year":"2014","unstructured":"Kallberg, M., Margaryan, G., Wang, S., Ma, J. & Xu, J. RaptorX server: A resource for template-based protein structure modeling. Methods Mol Biol. 1137, 17\u201327 (2014).","journal-title":"Methods Mol Biol."},{"key":"57906_CR30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.6026\/97320630012074","volume":"12","author":"VK Garg","year":"2016","unstructured":"Garg, V. K. et al. MFPPI - multi FASTA ProtParam interface. Bioinformation. 12, 74\u201377 (2016).","journal-title":"Bioinformation."},{"key":"57906_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.peptides.2014.07.005","volume":"59","author":"T Lafarga","year":"2014","unstructured":"Lafarga, T., O\u2019Connor, P. & Hayes, M. Identification of novel dipeptidyl peptidase-IV and angiotensin-I-converting enzyme inhibitory peptides from meat proteins using in silico analysis. Peptides. 59, 53\u201362 (2014).","journal-title":"Peptides."},{"key":"57906_CR32","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1093\/bioinformatics\/btq551","volume":"26","author":"CN Magnan","year":"2010","unstructured":"Magnan, C. N. et al. High-throughput prediction of protein antigenicity using protein microarray data. Bioinformatics. 26, 2936\u20132943 (2010).","journal-title":"Bioinformatics."},{"key":"57906_CR33","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.meegid.2013.11.011","volume":"21","author":"V Jaiswal","year":"2014","unstructured":"Jaiswal, V., Chauhan, R. S. & Rout, C. Common antigens prediction in bacterial bioweapons: A perspective for vaccine design. Infect Genet Evol. 21, 315\u2013319 (2014).","journal-title":"Infect Genet Evol."},{"key":"57906_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.7774\/cevr.2015.4.1.99","volume":"4","author":"S Delfani","year":"2015","unstructured":"Delfani, S. et al. In silico analysis for identifying potential vaccine candidates against staphylococcus aureus. Clin Exp Vaccine Res. 4, 99\u2013106 (2015).","journal-title":"Clin Exp Vaccine Res."},{"key":"57906_CR35","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","volume":"20","author":"I Dimitrov","year":"2014","unstructured":"Dimitrov, I., Bangov, I., Flower, D. R. & Doytchinova, I. AllerTOP v.2\u2013a server for in silico prediction of allergens. J Mol Model. 20, 2278, https:\/\/doi.org\/10.1007\/s00894-014-2278-5 (2014).","journal-title":"J Mol Model."},{"key":"57906_CR36","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3389\/fimmu.2018.00897","volume":"9","author":"GHW Tso","year":"2018","unstructured":"Tso, G. H. W., Reales-Calderon, J. A. & Pavelka, N. The elusive anti-candida vaccine: Lessons from the past and opportunities for the future. Front Immunol. 9, 897, https:\/\/doi.org\/10.3389\/fimmu.2018.00897 (2018).","journal-title":"Front Immunol."},{"key":"57906_CR37","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/j.1574-6976.2010.00232.x","volume":"34","author":"FL van de Veerdonk","year":"2010","unstructured":"van de Veerdonk, F. L., Netea, M. G., Joosten, L. A., van der Meer, J. W. & Kullberg, B. J. Novel strategies for the prevention and treatment of candida infections: The potential of immunotherapy. FEMS Microbiol Rev. 34, 1063\u20131075 (2010).","journal-title":"FEMS Microbiol Rev."},{"key":"57906_CR38","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/s0140-6736(72)91200-7","volume":"1","author":"HF Pabst","year":"1972","unstructured":"Pabst, H. F. & Swanson, R. Immunotherapy in candidiasis. Lancet. 1, 1022, https:\/\/doi.org\/10.1016\/s0140-6736(72)91200-7 (1972).","journal-title":"Lancet."},{"key":"57906_CR39","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/21505594.2014.1000752","volume":"6","author":"XJ Wang","year":"2015","unstructured":"Wang, X. J. et al. Vaccines in the treatment of invasive candidiasis. Virulence. 6, 309\u2013315 (2015).","journal-title":"Virulence."},{"key":"57906_CR40","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/S1567-5769(03)00016-X","volume":"3","author":"R Arnon","year":"2003","unstructured":"Arnon, R. & Ben-Yedidia, T. Old and new vaccine approaches. Int Immunopharmacol. 3, 1195\u20131204 (2003).","journal-title":"Int Immunopharmacol."},{"key":"57906_CR41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/jac\/dkx444","volume":"73","author":"F Lamoth","year":"2018","unstructured":"Lamoth, F., Lockhart, S. R., Berkow, E. L. & Calandra, T. Changes in the epidemiological landscape of invasive candidiasis. J Antimicrob Chemother. 73, 4\u201313 (2018).","journal-title":"J Antimicrob Chemother."},{"key":"57906_CR42","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1016\/S0264-410X(00)00554-5","volume":"19","author":"R Rappuoli","year":"2001","unstructured":"Rappuoli, R. Reverse vaccinology, a genome-based approach to vaccine development. Vaccine. 19, 2688\u20132691 (2001).","journal-title":"Vaccine."},{"key":"57906_CR43","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.immuni.2010.09.017","volume":"33","author":"A Sette","year":"2010","unstructured":"Sette, A. & Rappuoli, R. Reverse vaccinology: Developing vaccines in the era of genomics. Immunity. 33, 530\u2013541 (2010).","journal-title":"Immunity."},{"key":"57906_CR44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/vaccines6010012","volume":"6","author":"PC McCarthy","year":"2018","unstructured":"McCarthy, P. C., Sharyan, A. & Sheikhi Moghaddam, L. Meningococcal vaccines: Current status and emerging strategies. Vaccines (Basel). 6, 10, https:\/\/doi.org\/10.3390\/vaccines6010012 (2018).","journal-title":"Vaccines (Basel)."},{"key":"57906_CR45","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","volume":"287","author":"M Pizza","year":"2000","unstructured":"Pizza, M. et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science. 287, 1816\u20131820 (2000).","journal-title":"Science."},{"key":"57906_CR46","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1126\/science.1111563","volume":"309","author":"P Lauer","year":"2005","unstructured":"Lauer, P. et al. Genome analysis reveals pili in group B streptococcus. Science. 309, 105, https:\/\/doi.org\/10.1126\/science.1111563 (2005).","journal-title":"Science."},{"key":"57906_CR47","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1074\/mcp.M700295-MCP200","volume":"7","author":"F Berlanda Scorza","year":"2008","unstructured":"Berlanda Scorza, F. et al. Proteomics characterization of outer membrane vesicles from the extraintestinal pathogenic escherichia coli DeltatolR IHE3034 mutant. Mol Cell Proteomics. 7, 473\u2013485 (2008).","journal-title":"Mol Cell Proteomics."},{"key":"57906_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2009-10-9-r102","volume":"10","author":"RA Stabler","year":"2009","unstructured":"Stabler, R. A. et al. Comparative genome and phenotypic analysis of clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol. 10, R102, https:\/\/doi.org\/10.1186\/gb-2009-10-9-r102 (2009).","journal-title":"Genome Biol."},{"key":"57906_CR49","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1128\/IAI.70.1.368-379.2002","volume":"70","author":"S Montigiani","year":"2002","unstructured":"Montigiani, S. et al. Genomic approach for analysis of surface proteins in chlamydia pneumoniae. Infect Immun. 70, 368\u2013379 (2002).","journal-title":"Infect Immun."},{"key":"57906_CR50","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.3389\/fimmu.2018.02315","volume":"9","author":"FA Bidmos","year":"2018","unstructured":"Bidmos, F. A., Siris, S., Gladstone, C. A. & Langford, P. R. Bacterial vaccine antigen discovery in the reverse vaccinology 2.0 era: Progress and challenges. Front Immunol. 9, 2315, https:\/\/doi.org\/10.3389\/fimmu.2018.02315 (2018).","journal-title":"Front Immunol."},{"key":"57906_CR51","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/11303","volume":"5","author":"K Palucka","year":"1999","unstructured":"Palucka, K. & Banchereau, J. Linking innate and adaptive immunity. Nat Med. 5, 868\u2013870 (1999).","journal-title":"Nat Med."},{"key":"57906_CR52","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/21505594.2015.1004977","volume":"6","author":"JP Richardson","year":"2015","unstructured":"Richardson, J. P. & Moyes, D. L. Adaptive immune responses to candida albicans infection. Virulence. 6, 327\u2013337 (2015).","journal-title":"Virulence."},{"key":"57906_CR53","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1128\/IAI.74.1.362-369.2006","volume":"74","author":"MX Zhang","year":"2006","unstructured":"Zhang, M. X. et al. Human recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice. Infect Immun. 74, 362\u2013369 (2006).","journal-title":"Infect Immun."},{"key":"57906_CR54","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.3389\/fimmu.2017.01939","volume":"8","author":"PR Kumaresan","year":"2018","unstructured":"Kumaresan, P. R., da Silva, T. A. & Kontoyiannis, D. P. Methods of controlling invasive fungal infections using CD8(+) T cells. Front Immunol. 8, 1939, https:\/\/doi.org\/10.3389\/fimmu.2017.01939 (2018).","journal-title":"Front Immunol."},{"key":"57906_CR55","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1172\/JCI58762","volume":"122","author":"SG Nanjappa","year":"2012","unstructured":"Nanjappa, S. G., Heninger, E., Wuthrich, M., Sullivan, T. & Klein, B. Protective antifungal memory CD8(+) T cells are maintained in the absence of CD4(+) T cell help and cognate antigen in mice. J Clin Invest. 122, 987\u2013999 (2012).","journal-title":"J Clin Invest."},{"key":"57906_CR56","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1084\/jem.20030109","volume":"197","author":"M Wuthrich","year":"2003","unstructured":"Wuthrich, M., Filutowicz, H. I., Warner, T., Deepe, G. S. Jr. & Klein, B. S. Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: Implications for vaccine development in immune-deficient hosts. J Exp Med. 197, 1405\u20131416 (2003).","journal-title":"J Exp Med."},{"key":"57906_CR57","doi-asserted-by":"publisher","first-page":"13064","DOI":"10.1073\/pnas.1120585109","volume":"109","author":"JM Reynolds","year":"2012","unstructured":"Reynolds, J. M., Martinez, G. J., Chung, Y. & Dong, C. Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation. Proc Natl Acad Sci USA 109, 13064\u201313069 (2012).","journal-title":"Proc Natl Acad Sci USA"},{"key":"57906_CR58","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1189\/jlb.0110057","volume":"88","author":"E Davila","year":"2010","unstructured":"Davila, E. & Kolls, J. A \u201ctoll\u201d for Th17 cell expansion. J Leukoc Biol. 88, 5\u20137, https:\/\/doi.org\/10.1189\/jlb.0110057 (2010).","journal-title":"J Leukoc Biol."},{"key":"57906_CR59","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1021\/acs.molpharmaceut.5b00802","volume":"13","author":"M Li","year":"2016","unstructured":"Li, M., Jiang, Y., Gong, T., Zhang, Z. & Sun, X. Intranasal vaccination against HIV-1 with adenoviral vector-based nanocomplex using synthetic TLR-4 agonist peptide as adjuvant. Mol Pharm. 13, 885\u2013894 (2016).","journal-title":"Mol Pharm."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-57906-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-57906-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-57906-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T06:10:42Z","timestamp":1670307042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-57906-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,23]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["57906"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-57906-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,23]]},"assertion":[{"value":"29 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1066"}}